how many people are taking glp 1 for weight loss new Harvard-led study suggests women GLP-1 weight-loss medications like Ozempic and Wegovy may have an advantage in the job market.⁠ ⁠ Researchers found that unemployed women using GLP-1 medications were 27% GLP-1 Survey: 37.5% of People

the control group and included patients with T2D treated with conventional anti-diabetic therapy not including GLP-1RAs (n = 92)

Clin Gastroenterol Hepatol 11(1):4348 Kerby DS

Tao YX, Conn PM

Step 3: read the graph The output is a concentration-over-time graph

3 Johns Hopkins Drug Discovery, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA Correspondence: Soo Kyung Bae, College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, 14662, Republic of Korea, Email [email protected] Abstract: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are peptide-derived analogs that were initially investigated to treat type 2 diabetes